TAG:
lab acquisition
Pace of Lab Acquisitions Increased during 2009
By Robert Michel | From the Volume XVII No. 3 – February 15, 2010 Issue
CEO SUMMARY: After two years of relatively slow sales of clinical labs, there is pent up demand for lab acquisitions and a declining supply of independent labs available for sale. That’s the assessment of one expert on laboratory mergers and acquisitions, who predicts that the accelerat…
Predict 2010 To Be Busy For Lab Owners & Buyers
By Robert Michel | From the Volume XVII No. 3 – February 15, 2010 Issue
CEO SUMMARY: Along with a recovering economy, the possibility of an increase in the capital gains tax rate for 2011 may encourage owners of clinical labs and anatomic pathology companies to sell their businesses during 2010. That could make 2010 a busy year for laboratory…
Growth Conundrum Confronts Quest and LabCorp
By R. Lewis Dark | From the Volume XV No. 15 – November 10, 2008 Issue
AFTER MORE THAN TWO DECADES of buying up almost every attractive laboratory asset that came up for sale—and with few lab acquisition candidates left to buy—Laboratory Corporation of America and Quest Diagnostics Incorporated find themselves in an interesting conu…
LabCorp And Quest Report 3rd Quarter Financial Performance
By Robert Michel | From the Volume XV No. 15 – November 10, 2008 Issue
CEO Summary: In third quarter earnings reports, both national lab companies posted modest gains in specimen volume, revenue, and net profit. More telling is the relative quiet in the current market for lab testing services. With no obvious opportunities to fuel double-digit rates of growt…
September 08, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 12 – September 8, 2008 Issue
Here’s an update on the issue of why pathologists working in independent laboratories will not be paid under the Medicare Physician Quality Reporting Initiative (PQRI). (See TDR, August 18, 2008.) Last week, Donald McLeod, a spokesman at the federal Centers for Medicare & Medic…
Unprecedented Activity Across Lab Medicine
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: Laboratory medicine is now considered one of the best opportunities to profit as the demand for healthcare services skyrockets, both in the United States and throughout the world. This is why a flood of investment capital is washing into the laboratory industry. Loaded with c…
Quest, LabCorp Slug It Out In Battle for Market Share
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: In reporting second quarter earnings, both Laboratory Corporation of America and Quest Diagnostics Incorporated discussed market developments. There were no surprises in the comments made by executives of both companies. Quest Diagnostics emphasized that it is hanging on to a…
BRLI Seizes NYC Share In Two-Stage Effort
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Bio-Reference Laboratories, Inc., (BRLI) reported record financial results for its most recent fiscal quarter last month. Much of this success is rooted in BRLI’s discipline in defining itself as a local laboratory and using enhanced lab testing services to align itself as …
Sonic Pays $180 Million In Acquisition of AEL
By Robert Michel | From the Volume XIII No. 17 – December 18, 2006 Issue
CEO SUMMARY: In a transaction that was quietly negotiated, Sonic Healthcare Ltd. will purchase American Esoteric Laboratories, Inc. (AEL). News of the sale was released Friday and the sale may close in early January. Once it owns AEL, Sonic will have a major presence in Memphis, Tennessee…
2006’s Top Lab Stories Identify New Threats
By Robert Michel | From the Volume XIII No. 17 – December 18, 2006 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2006.” Compared to earlier years, 2006 was not transformative for the laboratory industry. But it was an eventful year, particularly influenced by Siemens’ decision to acquire DPC and Bayer Diagnostics, …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized